Skip to main content
Clinical Trials/IRCT2015122525641N2
IRCT2015122525641N2CompletedPhase 2

Effect of Curcumin in treatment of Non-Alcoholic Fatty Liver Disease: A Randomized Double-blind Clinical Trial Including Placebo

Vice chancellor for research of Baqiyatallah University of Medical Science0 sites100 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to 139 years (—)
Sex
All

Inclusion Criteria

  • patient has Fatty Liver; The history of allergic reaction to the drug combination is not relevant; Over 18 years old; The patient has informed consent to participate in the study;
  • Exclusion criteria:
  • The patient who stops the medication more than 1 week; The patient with the history of biliary disease; The patient with Fatty Liver, who also has Hyperlipidemia and receives statins; Patient with Fatty Liver, who also has another liver disease; Pregnancy and lactation; The patient who expresses uncontrolled adverse effects by this drug; alcohol consumption and any addictive drugs.

Exclusion Criteria

  • Not provided

Investigators

Sponsor
Vice chancellor for research of Baqiyatallah University of Medical Science

Similar Trials